Guggenheim Initiates Q32 Bio(QTTB.US) With Buy Rating, Announces Target Price $100

Guggenheim analyst Yatin Suneja initiates coverage on $Q32 Bio(QTTB.US)$ with a buy rating, and sets the target price at $100.According to TipRanks data, the analyst has a success rate of 44.6% and a

moomoo NewsJun 17 13:32 ET · Ratings

Market-Moving News for June 17th

BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106ZYME: 13% | Zymeworks shares are trading higher after the FDA cleared the company's Investigational New Drug application for Zw171

BenzingaJun 17 08:40 ET

Express News | Q32 Bio Shares Are Trading Higher After Guggenheim Initiated Coverage With a Buy Rating and a $100 Price Target

BenzingaJun 17 07:43 ET

Q32 Bio Initiated at Buy by Guggenheim

Q32 Bio Initiated at Buy by Guggenheim

Dow JonesJun 17 07:21 ET

Express News | Guggenheim Initiates Coverage On Q32 Bio With Buy Rating, Announces Price Target of $100

BenzingaJun 17 07:11 ET

Buy Rating Justified by Q32 Bio's Promising Pipeline and Market Potential

TipRanksMay 21 06:35 ET